Usona Institute

Usona Institute is dedicated to supporting and conducting preclinical and clinical research to further understand the therapeutic effects of psilocybin and other consciousness-enhancing drugs. Usona Institute focuses on alleviating depression in individuals whose current medical approaches are insufficient to relieve their suffering and improve their quality of life.Headquartered in Madison, Wisconsin, Usona was founded in 2014 by Bill Linton, CEO and founder of the international life sciences company Promega Corporation, and Malynn Utzinger, Director of Integrative Practices at Promega Corporation. The institute was established shortly after Bill was inspired by the meaningful impact of Johns Hopkins University's psilocybin research on a friend with cancer.